Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis
Open Access
- 8 March 2023
- journal article
- review article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (6) , 2464-2482
Abstract
No abstract availableKeywords
Funding Information
- Sichuan Provincial Science and Technology Support Program (2021YFQ0029)
- National Natural Science Foundation of China (82202989, 82273877)
- China Postdoctoral Science Foundation (2022M722279, 2023YFS0163)
- Fundamental Research Funds for the Central Universities
This publication has 137 references indexed in Scilit:
- Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expressionJournal of Controlled Release, 2015
- Immune cell promotion of metastasisNature Reviews Immunology, 2015
- Fluorescence MicroscopyCold Spring Harbor Protocols, 2014
- Cancer-related inflammation and treatment effectivenessThe Lancet Oncology, 2014
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsProceedings of the National Academy of Sciences, 2012
- Treating metastatic cancer with nanotechnologyNature Reviews Cancer, 2011
- Metastatic Cells Will Take Any Help They Can GetCancer Cell, 2011
- Leukocytes as paracrine regulators of metastasis and determinants of organ‐specific colonizationInternational Journal of Cancer, 2011
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Homing Receptors and Metastasis1988